Association between low bone mass and the serum RANKL and OPG in patients with nephrolithiasis
Abstract Background Nephrolithiasis is a risk factor for Osteopenia and osteoporosis. Receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin (OPG) regulate bone remodeling and osteoclastogenesis. This study aimed to evaluate the relation between serum OPG, RANKL concentration...
Main Authors: | Asieh Mansour, Maryam Aboeerad, Mostafa Qorbani, Amir Pejman Hashemi Taheri, Mohamad Pajouhi, Abbas Ali Keshtkar, Bagher Larijani, Mohammad Reza Mohajeri-Tehrani, Mohammad Reza Ganji |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-07-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12882-018-0960-z |
Similar Items
-
Adiponectin regulates bone mass in AIS osteopenia via RANKL/OPG and IL6 pathway
by: Hong-qi Zhang, et al.
Published: (2019-02-01) -
Anti-osteoporotic activity of sialoglycoproteins isolated from the eggs of Carassius auratus by promoting osteogenesis and increasing OPG/RANKL ratio
by: Guanghua Xia, et al.
Published: (2015-05-01) -
Changes in RANKL during the first two years after cART initiation in HIV-infected cART naïve adults
by: Inger Hee Mathiesen, et al.
Published: (2017-04-01) -
The effect of Phase 1 periodontal treatment on the salivary RANKL/OPG ratio in severe chronic periodontitis
by: Ansari Moghadam S, et al.
Published: (2019-08-01) -
The RANK/RANKL/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy
by: Sisay M, et al.
Published: (2017-07-01)